HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoko Matsuda Selected Research

H19 long non-coding RNA

10/2018H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells.
1/2018Expression and role of long non-coding RNA H19 in carcinogenesis.
1/2018Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoko Matsuda Research Topics

Disease

63Neoplasms (Cancer)
05/2022 - 01/2005
31Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 12/2008
26Adenocarcinoma
01/2022 - 05/2005
20Carcinogenesis
02/2022 - 05/2005
17Neoplasm Metastasis (Metastasis)
01/2021 - 01/2011
10Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 10/2007
8Melanoma (Melanoma, Malignant)
03/2020 - 06/2010
5Lung Neoplasms (Lung Cancer)
01/2022 - 07/2007
5Body Weight (Weight, Body)
03/2021 - 03/2006
5Carcinoma (Carcinomatosis)
01/2021 - 10/2007
5Adenoma (Adenomas)
01/2020 - 10/2007
5Fibrosis (Cirrhosis)
01/2020 - 12/2015
5Prostatic Neoplasms (Prostate Cancer)
01/2018 - 01/2011
4Inflammation (Inflammations)
02/2022 - 01/2020
4Glioblastoma (Glioblastoma Multiforme)
02/2015 - 01/2011
4Glioma (Gliomas)
02/2015 - 07/2011
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2015 - 02/2010
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2014 - 07/2007
3Breast Neoplasms (Breast Cancer)
01/2021 - 12/2008
3Stomach Neoplasms (Stomach Cancer)
02/2020 - 09/2017
3Brain Ischemia (Cerebral Ischemia)
01/2015 - 09/2013
3Adenocarcinoma of Lung
04/2014 - 12/2008
2Adenosquamous Carcinoma
01/2022 - 10/2012
2Triple Negative Breast Neoplasms
05/2021 - 01/2021
2Metaplasia
01/2021 - 04/2014
2Diabetes Mellitus
01/2020 - 01/2020
2Residual Neoplasm
11/2019 - 03/2018
2Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
03/2019 - 06/2016
2Immunoglobulin G4-Related Disease
06/2016 - 12/2015
2Reperfusion Injury
01/2015 - 09/2013
2Bowen's Disease (Disease, Bowen)
08/2014 - 12/2013
2Actinic Keratosis
08/2014 - 12/2013
2Uterine Cervical Dysplasia
08/2012 - 02/2010
2Hyperplasia
07/2009 - 09/2008
1Colonic Neoplasms (Colon Cancer)
05/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2022
1Crohn Disease (Crohn's Disease)
02/2022

Drug/Important Bio-Agent (IBA)

23NestinIBA
01/2021 - 01/2011
15Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2007
9Messenger RNA (mRNA)IBA
06/2016 - 03/2006
8Small Interfering RNA (siRNA)IBA
01/2021 - 03/2011
7Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
09/2014 - 02/2010
6Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2015
5Biological ProductsIBA
05/2021 - 07/2011
5CarbohydratesIBA
02/2020 - 09/2017
5Protein Isoforms (Isoforms)IBA
09/2014 - 02/2010
5LumicanIBA
08/2014 - 12/2008
4AntigensIBA
01/2021 - 09/2017
4Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
09/2012 - 02/2010
4Methoxsalen (Oxsoralen)FDA Link
07/2009 - 03/2006
44- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
07/2009 - 03/2006
3Estrogen ReceptorsIBA
05/2022 - 12/2008
3CytokinesIBA
02/2022 - 01/2005
3Monoclonal AntibodiesIBA
01/2022 - 09/2012
3Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 01/2020
3ParaffinIBA
01/2022 - 01/2011
3Carcinoembryonic AntigenIBA
12/2021 - 09/2017
3Peroxidase (Myeloperoxidase)IBA
11/2019 - 06/2016
3Eosine Yellowish-(YS) (Eosin)IBA
11/2019 - 01/2016
3GemcitabineFDA Link
01/2019 - 01/2016
3H19 long non-coding RNAIBA
10/2018 - 01/2018
3RNA (Ribonucleic Acid)IBA
01/2018 - 01/2011
3Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
09/2014 - 01/2012
3QuinoxalinesIBA
03/2010 - 09/2009
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2013
2Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 09/2017
2Formaldehyde (Formol)FDA Link
01/2022 - 01/2011
2Threonine (L-Threonine)FDA Link
01/2022 - 01/2020
2Keratins (Keratin)IBA
12/2021 - 01/2005
2CarcinogensIBA
06/2021 - 03/2010
2VimentinIBA
01/2021 - 01/2012
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2020 - 01/2017
2N-acetyltalosaminuronic acid (NAT)IBA
11/2019 - 01/2019
2Hematoxylin (Haematoxylon)IBA
10/2019 - 01/2016
2OligonucleotidesIBA
10/2019 - 04/2018
2SulfotransferasesIBA
10/2019 - 04/2018
2Double-Stranded RNA (RNA, Double Stranded)IBA
10/2019 - 04/2018
2STNM01IBA
10/2019 - 04/2018
2Histones (Histone)IBA
03/2019 - 08/2016
2Long Noncoding RNAIBA
10/2018 - 01/2018
2Adenosine Triphosphate (ATP)IBA
08/2018 - 04/2018
2AndrogensIBA
01/2017 - 06/2005
2Pharmaceutical PreparationsIBA
01/2017 - 08/2014
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
08/2016 - 06/2016
2Xanthine DehydrogenaseIBA
01/2015 - 01/2015
2Fixatives (Pickling Agents)IBA
01/2015 - 01/2011
2paraform (paraformaldehyde)IBA
01/2015 - 01/2011
2Cytoskeletal ProteinsIBA
05/2011 - 12/2010
2NitrosaminesIBA
10/2007 - 07/2007
2EnzymesIBA
07/2007 - 03/2006
2Tumor Viral Antigens (Large T Antigen)IBA
06/2005 - 05/2005
2probasinIBA
06/2005 - 05/2005
1Estrogens (Estrogen)FDA Link
05/2022
1Therapeutic UsesIBA
02/2022
1Lactulose (Duphalac)FDA LinkGeneric
02/2022

Therapy/Procedure

11Therapeutics
01/2022 - 02/2010
7Neoadjuvant Therapy
01/2022 - 03/2018
5Drug Therapy (Chemotherapy)
01/2021 - 02/2018
2Pancreatectomy
01/2022 - 01/2019
2Molecular Targeted Therapy
01/2013 - 07/2011